ADURO BIOTECH INC's ticker is ADRO and the CUSIP is 00739L101. A total of 80 filers reported holding ADURO BIOTECH INC in Q2 2015. The put-call ratio across all filers is - and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2016 | $22,760,000 | +4.5% | 1,996,489 | +13.9% | 0.00% | 0.0% |
| Q3 2016 | $21,781,000 | +15.7% | 1,752,256 | +5.2% | 0.00% | 0.0% |
| Q2 2016 | $18,833,000 | +43.1% | 1,665,187 | +62.0% | 0.00% | +33.3% |
| Q1 2016 | $13,165,000 | -49.8% | 1,027,701 | +10.3% | 0.00% | -50.0% |
| Q4 2015 | $26,213,000 | +589.3% | 931,515 | +374.5% | 0.01% | +500.0% |
| Q3 2015 | $3,803,000 | -36.6% | 196,326 | -0.8% | 0.00% | 0.0% |
| Q2 2015 | $6,002,000 | – | 197,898 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| HARVARD MANAGEMENT CO INC | 6,518,100 | $69,418,000 | 6.83% |
| BVF INC/IL | 184,764 | $1,968,000 | 0.25% |
| Rock Springs Capital Management LP | 415,000 | $4,420,000 | 0.20% |
| OAK RIDGE INVESTMENTS LLC | 432,050 | $4,601,000 | 0.19% |
| Vident Investment Advisory, LLC | 109,815 | $1,170,000 | 0.06% |
| Foundry Partners, LLC | 110,743 | $1,179,000 | 0.05% |
| Virtus ETF Advisers LLC | 30,685 | $327,000 | 0.04% |
| Trexquant Investment LP | 16,471 | $175,000 | 0.04% |
| ASCEND CAPITAL, LLC | 101,261 | $1,077,000 | 0.04% |
| Artal Group S.A. | 200,000 | $2,130,000 | 0.04% |